Skunk pharma

A case study of six leading pharmaceutical companies – Amgen, Elan, Lundbeck, Merck, UCB and Wyeth – by Annabeth Aagaard of the University of Southern Denmark points to how the industry might adapt to ongoing pressures from rising R&D costs, depreciating patent value and public authority desire to cut healthcare costs. “These challenges have increased […]

Seeding growth for Indian pharma

During the last two decades, India has emerged as a leading player in clinical trials, manufacturing and R&D of pharmaceuticals. Today, the Indian pharmaceutical industry is growing rapidly and ranks third in the world by volume sales (14th by value) amounting to US $20 billion with forecasters suggesting this will double well before the end […]

Pharma matters

The latest issue of my Cutting Edge of Chemistry report for TR Pharma Matters is now available. Organic synthesis scheme showcase in this report, we look at a chemoenzymatic approach that shows promise for a more efficient route to synthesize ultra low molecular weight heparins. Scaffolds on the move – dihydronaphthyridinediones could represent a novel […]